<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id>
      <journal-id journal-id-type="iso-abbrev">Emerging Infect. Dis</journal-id>
      <journal-id journal-id-type="publisher-id">EID</journal-id>
      <journal-title-group>
        <journal-title>Emerging Infectious Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1080-6040</issn>
      <issn pub-type="epub">1080-6059</issn>
      <publisher>
        <publisher-name>Centers for Disease Control and Prevention</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">22931561</article-id>
      <article-id pub-id-type="pmc">3437718</article-id>
      <article-id pub-id-type="publisher-id">11-1727</article-id>
      <article-id pub-id-type="doi">10.3201/eid1809.111727</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letters to the Editor</subject>
        </subj-group>
        <subj-group subj-group-type="article-type">
          <subject>Letter</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>bla</italic><sub>OXA-181</sub>&#x2013;positive <italic>Klebsiella pneumoniae</italic>, Singapore</article-title>
        <alt-title alt-title-type="running-head"><italic>bla</italic><sub>OXA-181</sub>&#x2013;positive <italic>K. pneumoniae</italic>, Singapore</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Koh</surname>
            <given-names>Tse H.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cao</surname>
            <given-names>Delphine Y.H.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chan</surname>
            <given-names>Kian S.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wijaya</surname>
            <given-names>Limin</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Low</surname>
            <given-names>Stewart B.G.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lam</surname>
            <given-names>Mun S.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ooi</surname>
            <given-names>Eng E.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hsu</surname>
            <given-names>Li-Yang</given-names>
          </name>
        </contrib>
        <aff id="aff1">National University of Singapore, Singapore (T.H. Koh, L.-Y. Hsu);</aff>
        <aff id="aff2">Singapore General Hospital, Singapore (T.H. Koh, D.Y.H. Cao, K.S. Chan, L. Wijaya);</aff>
        <aff id="aff3">Mount Alvernia Hospital, Singapore (S.B.G. Low);</aff>
        <aff id="aff4">Mount Elizabeth Medical Centre, Singapore (M.S. Lam);</aff>
        <aff id="aff5">and Duke&#x2013;National University of Singapore&#x2013;Graduate Medical School, Singapore (E.E. Ooi)</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address for correspondence: Tse H. Koh, Department of Pathology, Singapore General Hospital, Outram Rd, 169608 Singapore; email: <email xlink:href="koh.tse.hsien@sgh.com.sg">koh.tse.hsien@sgh.com.sg</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2012</year>
      </pub-date>
      <volume>18</volume>
      <issue>9</issue>
      <fpage>1524</fpage>
      <lpage>1525</lpage>
      <kwd-group kwd-group-type="author">
        <title>Keywords: </title>
        <kwd>carbapenemase</kwd>
        <kwd>oxacillinase</kwd>
        <kwd>bla<sub>OXA-181</sub></kwd>
        <kwd>Klebsiella pneumoniae</kwd>
        <kwd>antimicrobial drugs</kwd>
        <kwd>antibiotics</kwd>
        <kwd>drug resistance</kwd>
        <kwd>bacteria</kwd>
        <kwd>Bangladesh</kwd>
        <kwd>Singapore</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p><bold>To the Editor:</bold> Nordmann et al. (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>) raised concern over the global spread of carbapenemase-producing <italic>Enterobacteriaceae</italic>. In their article, they called attention to the oxacillinase-48 (OXA-48) type carbapenemases because bacteria that produce these enzymes do not have a distinctive antimicrobial drug susceptibility profile, and there is less awareness of this mechanism of carbapenem resistance. We report the recent isolation of <italic>bla</italic><sub>OXA-181</sub>&#x2013;positive <italic>Klebsiella pneumoniae</italic> from 2 patients from Bangladesh who were admitted to separate hospitals in Singapore within a short period of each other.</p>
    <p>The first patient was a 64-year-old man who had a recent heart attack and was transferred from a hospital in Dhaka, Bangladesh, to a hospital in Singapore for treatment for pancytopenia. He had no other history of recent travel. While in Bangladesh, the patient had <italic>Pseudomonas</italic> spp. bacteremia and had received meropenem and vancomycin. In Singapore, his antimicrobial drug treatment regimen was changed to ciprofloxacin, linezolid, and amikacin. Blood samples obtained on the day of admission were cultured and grew a vancomycin-resistant <italic>Enterococcus</italic> spp. and a carbapenem-resistant <italic>K. pneumoniae</italic> (isolate DB53879_11).</p>
    <p>Two days after admission, when the results of his blood culture were known, the patient&#x2019;s antimicrobial drug treatment regimen was changed to oral linezolid (600 mg every 12 hours), intravenous tigecycline (initially 50 mg every hour but later increased to 100 mg every 12 hours), and intravenous polymyxin E (initially 3 MU/d but later increased to 3 MU every 12 hours). Blood cultured for <italic>K. pneumoniae</italic> showed positive results for 5 days after the patient was hospitalized before clearing.</p>
    <p>Isolate DB53879_11 was resistant to many antimicrobial drugs as determined by Etest (bioM&#xE9;rieux, Marcy l&#x2019;Etoile, France) (<xref ref-type="table" rid="T1">Table</xref>). It was strongly positive for carbapenemase production as determined by use of a modified Hodge test (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>) and showed a negative result with the KPC + MBL Confirm ID Kit (Rosco Diagnostica A/S, Taastrup, Denmark).</p>
    <table-wrap id="T1" position="float">
      <label>Table</label>
      <caption>
        <title>Antimicrobial drug susceptibilities of 3 <italic>bla</italic><sub>OXA-181</sub>&#x2013;positive <italic>Klebsiella pneumoniae</italic> isolates, Singapore*</title>
      </caption>
      <table frame="hsides" rules="groups">
        <col width="128" span="1"/>
        <col width="72" span="1"/>
        <col width="58" span="1"/>
        <col width="57" span="1"/>
        <thead>
          <tr>
            <th rowspan="2" valign="bottom" align="left" scope="col" colspan="1">Drug</th>
            <th valign="bottom" colspan="3" align="center" scope="colgroup" rowspan="1">MIC (mg/L)<hr/></th>
          </tr>
          <tr>
            <th valign="bottom" colspan="1" align="center" scope="colgroup" rowspan="1">DB53879_11</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">DX1083_11</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">BL21479_11</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ampicillin</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;256</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;256</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;256</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Amoxicillin/clavulanate</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;256</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;256</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;256</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Piperacillin/tazobactam</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;256</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;256</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;256</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Cefuroxime</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;256</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;256</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;256</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ceftriaxone</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;32</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;32</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;32</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ceftazidime</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;256</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;256</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;256</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Cefepime</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;256</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;256</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;256</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ertapenem</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;32</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;32</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;32</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Imipenem</td>
            <td valign="top" align="center" rowspan="1" colspan="1">16</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;32</td>
            <td valign="top" align="center" rowspan="1" colspan="1">16</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Meropenem</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;32</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;32</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;32</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Doripenem</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;32</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;32</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;32</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ciprofloxacin</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;32</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;32</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;32</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Levofloxacin</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;32</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;32</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;32</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Gentamicin</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;256</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;256</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;256</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Amikacin</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;256</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;256</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;256</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sulfamethoxazole/trimethoprim</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;32</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;32</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;32</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Tetracycine</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;256</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2265;256</td>
            <td valign="top" align="center" rowspan="1" colspan="1">8</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Tigecycline</td>
            <td valign="top" align="center" rowspan="1" colspan="1">4</td>
            <td valign="top" align="center" rowspan="1" colspan="1">4</td>
            <td valign="top" align="center" rowspan="1" colspan="1">4</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Polymyxin B</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.5</td>
            <td valign="top" align="center" rowspan="1" colspan="1">1</td>
            <td valign="top" align="center" rowspan="1" colspan="1">4</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <p>*OXA-181, oxacillinase-181.</p>
      </table-wrap-foot>
    </table-wrap>
    <p>Using PCR, we amplified and sequenced a product identical to the complete sequence of <italic>bla</italic><sub>OXA-181</sub>. Primers designed for known flanking regions of <italic>bla</italic><sub>OXA-181</sub> (GenBank accession no. JN205800) failed to amplify any product. Like described isolates (<xref ref-type="bibr" rid="R3"><italic>3</italic></xref>&#x2013;<xref ref-type="bibr" rid="R5"><italic>5</italic></xref>), DB53879_11 was also positive for <italic>bla</italic><sub>OXA-1</sub> and <italic>bla</italic><sub>CTX-M-15</sub>, but it also was positive for <italic>bla</italic><sub>CMY-4</sub>. An attempt to transfer <italic>bla</italic><sub>OXA-181</sub> to azide-resistant <italic>Escherichia coli</italic> J53 by plate mating was unsuccessful.</p>
    <p>Two weeks after we received the specimen from the first patient, we were referred 2 carbapenem-resistant <italic>K. pneumoniae</italic> strains isolated from sputum (isolate DX1083_11) and blood (isolate BL21479_11) from a 30 year-old man admitted to another hospital in Singapore. He had been treated in the same hospital in Dhaka as the first patient for multiorgan failure secondary to dengue shock syndrome. Antimicrobial drug susceptibility phenotypes and resistance gene complements for DX1083_11 and BL21479_11were similar to those for the isolate from the first patient. The second patient received intravenous tigecycline, polymyxin B, and meropenem.</p>
    <p>All 3 isolates were identical when tested by random amplification of polymorphic DNA (<xref ref-type="bibr" rid="R6"><italic>6</italic></xref>) and by pulsed-field gel electrophoresis after restriction endonuclease digestion of chromosomal DNA with <italic>Spe</italic>I. Multilocus sequence typing showed that DX1083_11 belonged to sequence type 14 (<ext-link ext-link-type="uri" xlink:href="http://www.pasteur.fr/recherche/genopole/PF8/mlst/Kpneumoniae.html">www.pasteur.fr/recherche/genopole/PF8/mlst/Kpneumoniae.html</ext-link>). This sequence type is the same as that for <italic>bla</italic><sub>OXA-181</sub>&#x2013;positive <italic>K. pneumoniae</italic> reported from New Zealand (<xref ref-type="bibr" rid="R3"><italic>3</italic></xref>). Both patients died of their illnesses.</p>
    <p>OXA-181 is a close relative of OXA-48 from which it differs by 4 aa (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>). <italic>bla</italic><sub>OXA-181</sub>&#x2013;positive <italic>K. pneumonia</italic> infections were first described in India but imported cases have since been described in Oman, the Netherlands, and New Zealand (<xref ref-type="bibr" rid="R3"><italic>3</italic></xref>&#x2013;<xref ref-type="bibr" rid="R5"><italic>5</italic></xref>,<xref ref-type="bibr" rid="R7"><italic>7</italic></xref>). We were unable to confirm the original source of these isolates, and continuous surveillance for carbapenemase producers in our hospital has not uncovered any <italic>bla</italic><sub>OXA-181</sub>&#x2013;positive isolates since 1996. To our knowledge, there are no reports of <italic>bla</italic><sub>OXA-181</sub>&#x2013;positive isolates in Bangladesh. However, this country borders India, which is a source of <italic>bla</italic><sub>OXA-181</sub>&#x2013;positive <italic>Enterobacteriaceae</italic>. These cases highlight potential problems that may arise from medical tourism (the rapidly increasing practice of traveling across international borders to obtain health care) and document the expanding range of a newly emerging mechanism of carbapenem resistance.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="citation">
        <p><italic>Suggested citation for this article</italic>: Koh TH, Cao DYH, Chan KS, Wijaya L, Low SBG, Lam MS, et al. <italic>bla</italic><sub>OXA-181</sub>&#x2013;positive <italic>Klebsiella pneumoniae</italic>, Singapore [letter]. Emerg Infect Dis [serial on the Internet]. 2012 Sep [<italic>date cited</italic>]. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3201/eid1809.111727">http://dx.doi.org/10.3201/eid1809.111727</ext-link></p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgments</title>
      <p>We thank Tan Peck Lay and Ong Lan Huay for technical assistance and Zerrin Aktas for providing the <italic>K. pneumoniae bla</italic><sub>OXA-48</sub>&#x2013;positive control strain.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Nordmann</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Naas</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Poirel</surname>
<given-names>L</given-names></string-name>
<article-title>Global spread of carbapenemase-producing <italic>Enterobacteriaceae.</italic></article-title>
<source>Emerg Infect Dis</source>. <year>2011</year>;<volume>17</volume>:<fpage>1791</fpage>&#x2013;<lpage>8</lpage><pub-id pub-id-type="pmid">22000347</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2. </label>
        <mixed-citation publication-type="book"><collab>Clinical and Laboratory Standards Institute</collab> Performance standards for antimicrobial susceptibility testing. Document M100&#x2013;S21. 21st informational supplement. Wayne (PA): The Institute; <year>2011</year></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Williamson</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Heffernan</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Sidjabat</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Roberts</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Paterson</surname>
<given-names>DL</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>M</given-names></string-name>, <etal/>
<article-title>Intercontinental transfer of OXA-181&#x2013;producing <italic>Klebsiella pneumoniae</italic> into New Zealand.</article-title>
<source>J Antimicrob Chemother</source>. <year>2011</year>;<volume>66</volume>:<fpage>2888</fpage>&#x2013;<lpage>90</lpage>
<pub-id pub-id-type="doi">10.1093/jac/dkr396</pub-id><pub-id pub-id-type="pmid">21933789</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Potron</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Nordmann</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Lafeuille</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Al Maskari</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Al Rashdi</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Poirel</surname>
<given-names>L</given-names></string-name>
<article-title>Characterization of OXA-181, a carbapenem-hydrolyzing class D &#x3B2;-lactamase from <italic>Klebsiella pneumoniae.</italic></article-title>
<source>Antimicrob Agents Chemother</source>. <year>2011</year>;<volume>55</volume>:<fpage>4896</fpage>&#x2013;<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1128/AAC.00481-11</pub-id><pub-id pub-id-type="pmid">21768505</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Castanheira</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Deshpande</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>Mathai</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Bell</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Jones</surname>
<given-names>RN</given-names></string-name>, <string-name><surname>Mendes</surname>
<given-names>RE</given-names></string-name>
<article-title>Early dissemination of NDM-1- and OXA-181&#x2013;producing <italic>Enterobacteriaceae</italic> in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006&#x2013;2007.</article-title>
<source>Antimicrob Agents Chemother</source>. <year>2011</year>;<volume>55</volume>:<fpage>1274</fpage>&#x2013;<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1128/AAC.01497-10</pub-id><pub-id pub-id-type="pmid">21189345</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Vogel</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Jones</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Triep</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Koek</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Dijkshoorn</surname>
<given-names>L</given-names></string-name>
<article-title>RAPD typing of <italic>Klebsiella pneumoniae, Klebsiella oxytoca, Serratia marcescens</italic> and <italic>Pseudomonas aeruginosa</italic> isolates using standardized reagents.</article-title>
<source>Clin Microbiol Infect</source>. <year>1999</year>;<volume>5</volume>:<fpage>270</fpage>&#x2013;<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-0691.1999.tb00140.x</pub-id><pub-id pub-id-type="pmid">11856266</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Kalpoe</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Al Naiemi</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Poirel</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Nordmann</surname>
<given-names>P</given-names></string-name>
<article-title>Detection of an ambler class D OXA-48-type &#x3B2;-lactamase in a <italic>Klebsiella pneumoniae</italic> strain in the Netherlands.</article-title>
<source>J Med Microbiol</source>. <year>2011</year>;<volume>60</volume>:<fpage>677</fpage>&#x2013;<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1099/jmm.0.028308-0</pub-id><pub-id pub-id-type="pmid">21252273</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
